Diffuse Large B-Cell Lymphomas Are Metabolically Heterogeneous

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2012-188
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

Microenvironment Expression in Diffuse Large B-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Diffuse Large B-Cell Lymphoma: A Heterogeneous Group of Non-Hodgkin Lymphomas Comprising Several Distinct Clinicopathological Entities

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

A Study of the Newer Prognostic Markers in Diffuse Large B Cell Lymphomas

Medical Journal Armed Forces India
Medicine
2011English

Novel BCL6 Inhibitor (FX1): Advances in Diffuse Large B-Cell Lymphomas (DLBCLs) Treatment

Biomedical Sciences
2017English

FBXO11 Targets BCL6 for Degradation and Is Inactivated in Diffuse Large B-Cell Lymphomas

Nature
Multidisciplinary
2012English

Diffuse Large B-Cell Lymphoma

2020English

Reflectance Confocal Microscopy in the Diagnosis of Primary Cutaneous Diffuse Large B-Cell Lymphomas

ROMANIAN JOURNAL OF CLINICAL AND EXPERIMENTAL DERMATOLOGY
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy